Gene and cell therapy based treatment strategies for inflammatory bowel diseases

doi:10.4291/wjgp.v2.i6.114

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 2, Issue 6

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5941)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-2) series.

Item

Count

PDF

522

HTML

5086

Figures (1-1)

182

Tables (1-2)

151

Sum=5941

Dec 15, 2011 (publication date) through Apr 17, 2024

Times Cited of This Article

Times Cited (18)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Pathophysiology

ISSN

2150-5330

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastrointest Pathophysiol. Dec 15, 2011; 2(6): 114-122
Published online Dec 15, 2011. doi: 10.4291/wjgp.v2.i6.114

Open in New Tab Full Size Figure Download Figure

Figure 1 Emerging treatments for inflammatory bowel diseases. Overview of the gene and cell therapy based treatment strategies for inflammatory bowel diseases as discussed in this review. Treg: CD4⁺CD25^highFOXP3⁺ regulatory T cell; Tr1: Type 1 regulatory T cell; MSC: Mesenchymal stromal cells.

Citation: Marel SVD, Majowicz A, Deventer SV, Petry H, Hommes DW, Ferreira V. Gene and cell therapy based treatment strategies for inflammatory bowel diseases. World J Gastrointest Pathophysiol 2011; 2(6): 114-122
URL: https://www.wjgnet.com/2150-5330/full/v2/i6/114.htm
DOI: https://dx.doi.org/10.4291/wjgp.v2.i6.114